Company
Australian Primary Hemp Limited
Headquarters: Geelong, VIC, Australia
Market Cap
A$28.2 Million
AUD as of May 1, 2022
US$19.9 Million
Australian Primary Hemp Limited Categories
Australia Healthcare Drug Manufacturers—Specialty & GenericAustralia Healthcare Australia Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
| Company | Market Cap (USD) |
|---|---|
| Zoetis Inc. | $89.09 B |
| MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
| Takeda Pharmaceutical Company Limited | $47.71 B |
| Haleon plc | $38.90 B |
| PPD, Inc. | $16.58 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Australian Primary Hemp Limited manufactures and distributes hemp products under the Australian Primary Hemp brand to retail, wholesale, and white label customers in Australia. The company offers hemp seeds, cold pressed hemp oil, hemp fiber powder, hemp flour, hemp protein powder, hemp and bush balm mint hand sanitizers, hemp boost, hemp balance, and hemp and honey nut bars. It is also involved in the cultivation and production of hemp; handling various areas of hemp seed selection, farming, processing, and distribution; hemp contract packaging; and bulk and retail sale of edible hemp products. The company was founded in 2016 and is headquartered in Geelong, Australia.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Australian Primary Hemp Limited has the following listings and related stock indices.
Stock: ASX: APH wb_incandescent